LUCD

Lucid Diagnostics Inc. is a commercial-stage medical diagnostics technology company focused on esophageal cancer detection. The company develops non-invasive tests for early detection of esophageal precancer and cancer, including the EsoGuard test. Their technology aims to improve patient outcomes through earlier diagnosis of esophageal adenocarcinoma and its precursor condition, Barrett's esophagus.